To establish the prototype of human genome database based on 10,000 Thai individuals and the systemic prototype of pharmacogenomics for RDU
To launch the genetic testing service empowered by the NGS technology, for example, the estimation of genetic risk factors to develop breast cancer, the drug response prediction by testing 100 pharmacogenes, and the efficient digital genomic database to support clinical services.
To establish the clinical guidelines for making use of genomic data for various applications involved in precision medicine and to provide the genomic tests for the Neonatal Intensive Care Unit (NICU).
To provide the policy and legislation for protecting the privacy of human DNA samples and the results of DNA analysis.
To enable a cross-platform analysis of different genomics datasets, i.e., between human and microbe to dissect the complex traits and genetic diseases